Data are not reported here for subgroups with TZD owing to the low number of subjects receiving TZD in these trials: 5.4% and 2.3% of subjects receiving background TZD in SUSTAIN 2 and SUSTAIN 3, respectively [9, 10], and TZD was not included as a background therapy in SUSTAIN 4 or SUSTAIN 10 [11, 17]
It functions by activating GLP-1 receptors to regulate appetite and promote a feeling of fullness, which can contribute to reduced caloric intake
This does not eliminate muscle loss entirely, nothing can during significant caloric restriction, but it tilts the balance meaningfully
For patients in rural or underserved areas, telehealth can be especially valuable, allowing them to receive expert medical advice and treatment without the burden of long travel
Smart is truly dedicated to his Texas patients
Zhongguo Ying Yong Sheng li xueza zhi Chin J Appl Physiol 35:245249